CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75.2% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Novavax NVAX

Novavax live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Novavax news

Emma Rose 2025 Jul 03, 08:35

US Economy on Stagflation Watch: Apollo Global Management's Outlook

Ava Grace 2025 Jul 03, 08:35

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Sophia Claire 2025 Jul 03, 07:35

S&P 500 Earnings Season to Test Rally Amidst Dim Outlook

Sophia Claire 2025 Jul 03, 07:35

AI Podcast: Stock Market Melt-Up Potential? Examining the Bull Run

Noah Lee 2025 Jul 03, 07:35

AI Podcast: Does the Gold-Platinum Ratio Signal Stock Market Risk?

Latest news

Show more

Info

Spread

0.05

Spread (%)

0.6878 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

13:31 - 19:59

Monday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1209915904

Shares Outstanding

161970000

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

2.75

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Jul 28, 16:00

VisionWave Stock (VWAV) Surges: What Drives the VWAV Stock Prices?

Stocks
Ghko B 2025 Jul 28, 16:00

Ethereum (ETH-USD) Eyes $10K: How to Trade Ethereum CFD?

Crypto
Ghko B 2025 Jul 28, 16:00

What Is Stellar (XLM): How to Trade Stellar (XLM) CFDs?

Crypto
Trustpilot